How much is sofosbuvir and velpatasvir (Epclusa) reimbursed by medical insurance and what is the medical insurance price?

Sofosbuvir Velpatasvir (Epclusa) contains the combination of sofosbuvir (Sofosbuvir) and velpatasvir (velpatasvir). Sofosbuvir and velpatasvirare antiviral drugs that prevent hepatitis C virus (HCV) from multiplying in the body. Sofosbuvir and velpatasvir combination is indicated for the treatment of chronic hepatitis C in adults and children 3 years of age and older (dose is based on weight), and is sometimes used in combination with ribavirin, another antiviral drug, in patients with advanced cirrhosis.

The fosbuvir-velpatasvir combination treats specific genotypes of hepatitis C and is only effective in specific populations. Use only the medications your doctor prescribes for you, and do not use this combination of medications with others. The combination fosbuvir and velpatasvir is sometimes used in people living with HIV, but this drug is not used to treat HIV or AIDS. Fosbuvir and velpatasvir combination are only available through your doctor's prescribing information.

The original drug of sofosbuvir and velpatasvir has been launched in China and has entered the scope of Class B medical insurance. The domestic trade name is Bintongsha, and the specification is (400mg+100mg) * 28 tablets. The price per box is around RMB 4,000. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. The original drug of sofosbuvir and velpatasvir has also been launched overseas. There are also generic drugs of sofosbuvir and velpatasvir produced in other countries. The specifications of the Bangladesh Everest Pharmaceutical Factory are (400mg + 100mg) * 28 tablets per box, and the price is around RMB 850 (the price may fluctuate due to the exchange rate). The generic drugs produced abroad are basically the same as the original drugs at home and abroad.